News tips for Wednesday, Nov. 12, 2003

2 p.m. Abstract #3544 Results of hormone replacement study get rapid acceptance. Findings of last year's Women's Health Initiative (WHI) trial that hormone replacement therapy (HRT) with estrogen (E) plus progesterone (P) in post-menopausal women leads to excessive risk of cardiovascular disease is resulting in a "clear global decrease" in the use of HRT, a new study finds. Researchers assessed the impact of the WHI publication among 6,623 women, age 55 and over, taking part in an ongoing international drug trial. They found that 3.4 percent of North American women in that study were on E+P HRT after the WHI report, down from 5.9 percent before the report. Their results indicate a rapid acceptance of the results of the WHI trial both in North America and other countries, the scientists say. And despite a lack of data on effects of HRT with E alone, this therapy also was down in North American women, from 26 percent of post-menopausal women before the WHI report to 17.7 percent after.

2:15 p.m. Abstract #3099 Excess daytime sleepiness affects angina patients' quality of life. Sleep disturbances are a common problem among patients with coronary artery disease (CAD). New research finds that excessive daytime sleepiness predicts a poorer quality of life of CAD patients with chronic stable angina (chest pain). The Emory University study of 57 angina patients assessed quality of life (QOL) aspects via standard questionnaires, at baseline and follow-ups of one, three and four months. Extent of daytime sleepiness also was evaluated along with numerous other factors including years with CAD, body mass index and extent of other health problems. After controlling for clinical and demographic variables, researchers found daytime sleepiness to be "a significant negative predictor of QOL" in four statistical models studied. "Daytime sleepiness had pervasive and detrimental effects on chronic angina patients' QOL including generic and disease-s

Contact: Carole Bullock
American Heart Association

Page: 1 2 3 4

Related medicine news :

1. News tips for Wednesday, November 10, 2004

Post Your Comments:

(Date:10/9/2015)... ... October 09, 2015 , ... The American Osteopathic Foundation (AOF) ... Medical Education J. Michael Finley, DO, as the recipient of the 2015 W. ... impact on graduate medical education opportunities for osteopathic residents, and his dedication to ...
(Date:10/9/2015)... ... 09, 2015 , ... "My spouse and I rely on canes to walk, ... said an inventor from Buffalo, N.Y. "This is not only frustrating but it’s unsanitary. ... REST enables a user to keep a cane upright while it’s not in use. ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... ... company, has announced the final product specifications for TRACTUS, the world’s first sterile ... in the United States in response to the FDA’s recent Unique Device Identifier ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... "As a ... two inventors from Philadelphia, Pa. "They have to wear large diapers or pads. We ... , They developed the TROUSAFE to absorb urine leaking from the tip of the ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... ... one of the oldest and largest recreational dispensaries in Colorado, says the latest ... business is growing rapidly and maturing into a legitimate industry. , Last ...
Breaking Medicine News(10 mins):
(Date:10/9/2015)... Maryland , October 9, 2015 ... Inc. (OTCQB: CNBX) has announced its execution of an Intellectual ... & Liabilities Agreement with Cannabics, Inc. a Delaware Corporation, related ... company. --> --> ... restructuring of the Company, whereby the Research and Development ...
(Date:10/9/2015)... ClinicalKey Nursing debuts at ANCC National ... Elsevier , a world-leading provider of scientific, technical and ... Nursing , a new clinical reference platform that will provide ... nursing professionals. Attendees of the ANCC National Magnet Conference ... have the opportunity to demo ClinicalKey Nursing at booth #1309. ...
(Date:10/9/2015)... 2015 Eli Lilly and Company (NYSE: LLY ... approximately 50 new jobs to its research and development presence ... York, New York . --> ... will include a translational immuno-oncology hub and a Lilly "portal," ... access to cutting-edge drug discovery capabilities, including chemistry and lead ...
Breaking Medicine Technology:
Cached News: